{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:01:25Z","timestamp":1769000485202,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"DOI":"10.1086\/421953","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T14:49:35Z","timestamp":1096901375000},"page":"S176-S180","source":"Crossref","is-referenced-by-count":18,"title":["Design Issues in a Prospective Randomized Double-Blinded Trial of Prophylaxis with Fluconazole versus Voriconazole after Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1093","volume":"39","author":[{"given":"John R.","family":"Wingard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"key\n\t\t\t\t20171014022850_ref1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001432-200108000-00004","article-title":"Antifungal prophylaxis in hematopoietic stem cell transplant recipients","volume":"14","author":"Marr","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20171014022850_ref2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1086\/340263","article-title":"Antifungal chemoprophylaxis after blood and marrow transplantation","volume":"34","author":"Wingard","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"RR-10","key":"key\n\t\t\t\t20171014022850_ref3","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among hematopoietic cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation [abstract]","volume":"49","author":"Dykewicz","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014022850_ref4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014022850_ref5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis: disease spectrum, treatment practices, and outcomes","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20171014022850_ref6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Randomized comparison of voriconazole and amphotericin B in primary therapy for invasive aspergillosis: a collaborative study of the EORTC Invasive Fungal Infections Study Group and the Global Aspergillus Study Group","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014022850_ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022850_ref8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014022850_ref9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014022850_ref10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014022850_ref11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00007890-199604270-00026","article-title":"Evaluation of the drug interaction between high-dose (400 mg\/day) IV fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients","volume":"61","author":"Osowski","year":"1996","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171014022850_ref12","first-page":"24","article-title":"The effect of voriconazole on the pharmacokinetics of cyclosporin [abstract 845]","volume-title":"Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto)","author":"Ghahramani","year":"2000"},{"key":"key\n\t\t\t\t20171014022850_ref13","first-page":"2","article-title":"Effect of voriconazole on the pharmacokinetics of tacrolimus [abstract A-20]","volume-title":"Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago)","author":"Wood","year":"2001"},{"key":"key\n\t\t\t\t20171014022850_ref14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplantation","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014022850_ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1703332","article-title":"Late onset of invasive aspergillosis infection in bone marrow transplant patients at a university hospital","volume":"29","author":"Groh","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20171014022850_ref16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/39\/Supplement_4\/S176\/20905748\/39-Supplement_4-S176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T06:28:57Z","timestamp":1507962537000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/39\/Supplement_4\/S176\/320941\/Design-Issues-in-a-Prospective-Randomized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":16,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2004,10,15]]},"published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1086\/421953","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10,15]]},"published":{"date-parts":[[2004,10,15]]}}}